Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Movelat gel
1003020W0BBABAA
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 24,593 |
|
Movelat cream
1003020W0BBAAAB
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 8,885 |
|
Movelat Relief gel
1003020W0BBADAA
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 966 |
|
Movelat Relief cream
1003020W0BBACAB
|
Movelat | Heparinoid | Musculoskeletal and Joint Diseases | 528 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.